Viridian Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 1S1.F | ROIV | SEPN | VKTX | BHVN | IDYA | |
|---|---|---|---|---|---|---|
| Market cap | 2.52B | 27.61B | 2.23B | 3.57B | 2.30B | 3.12B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -8.4 | -27.5 | -24.7 | -5.5 | -8.2 | -7.9 |
| Price/book | 5.0 | 6.5 | 5.7 | 6.1 | -23.4 | 2.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +15.67% | +85.85% | +154.68% | −24.95% | +78.66% | +8.41% |
| Today | −0.89% | +6.08% | +9.57% | +7.21% | −2.37% | +3.29% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All 1S1.F news ›Analysts’ Opinions Are Mixed on These Healthcare Stocks: Viridian Therapeutics (VRDN), Align Tech (ALGN) and Gilead Sciences (GILD)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Viridian Therapeutics (VRDN), Align Tech (ALGN) and Gilead Sciences (GILD). Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Viridian…
Invivyd (NASDAQ:IVVD) vs. Viridian Therapeutics (NASDAQ:VRDN) Head to Head Comparison
Posted by Mitch Edgeman on Nov 1st, 2026 Invivyd (NASDAQ:IVVD – Get Free Report) and Viridian Therapeutics (NASDAQ:VRDN – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies…
More from 1 other outlet
Analysts’ Opinions Are Mixed on These Healthcare Stocks: CVRx (CVRX), Butterfly Network (BFLY) and Viridian Therapeutics (VRDN)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on CVRx (CVRX), Butterfly Network (BFLY) and Viridian Therapeutics (VRDN). In a report released today, Matthew O’Brien from Piper Sandler reiterated a Hold…
Viridian Therapeutics (VRDN) Set to Announce Quarterly Earnings on Wednesday
Posted by Danessa Lincoln on Oct 28th, 2026 NASDAQ:VRDN opened at $24.09 on Wednesday. The business’s 50-day moving average is $21.65 and its two-hundred day moving average is $22.05. The firm has a market capitalization of $2.73 billion,…
Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026
BioSpace Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026 WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com2
- biospace.com1
- defenseworld.net1
- markets.businessinsider.com1
- theglobeandmail.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.